Unique ID issued by UMIN | UMIN000031936 |
---|---|
Receipt number | R000036474 |
Scientific Title | Immunological and histological profiles in peripheral-blood and tumor-infiltrating immune cells and immune-related factors through overall treatment time in patients with renal cell carcinoma: an exploratory study |
Date of disclosure of the study information | 2018/03/28 |
Last modified on | 2019/03/29 12:02:18 |
Immunological and histological profiles in peripheral-blood and tumor-infiltrating immune cells and immune-related factors through overall treatment time in patients with renal cell carcinoma: an exploratory study
Immunological and histological profiles in peripheral-blood and tumor-infiltrating immune cells and immune-related factors through overall treatment time in patients with renal cell carcinoma: an exploratory study
Immunological and histological profiles in peripheral-blood and tumor-infiltrating immune cells and immune-related factors through overall treatment time in patients with renal cell carcinoma: an exploratory study
Immunological and histological profiles in peripheral-blood and tumor-infiltrating immune cells and immune-related factors through overall treatment time in patients with renal cell carcinoma: an exploratory study
Japan |
Renal cell carcinoma
Urology |
Malignancy
NO
To examine the profiles of immune cells and immune-related factors in peripheral blood and tumor tissue before and after each treatment for advanced renal cell carcinoma
Others
Immunological profile
The profile of immune cells in peripheral blood and tumor tissue
The profile of immune-related cytokines in serum
The expression of tumor-infiltrating lymphocytes and immune-related molecules in tumor tissue
Observational
Not applicable |
Not applicable |
Male and Female
Patients with metastatic or locally-advanced renal cell carcinoma who receive resection of the primary and/or metastatic lesions and systemic drug therapy
Patients receiving any anti-cancer drug for other malignancy
Patients receiving any systemic immune-suppressive therapy
Patients judged as unsuitable by their attending physician
40
1st name | Hirotsugu |
Middle name | |
Last name | Uemura |
Kindai University Faculty of Medicine
Department of Urology
540-0005
377-2, Ohno-higashi, Osaka-sayama, Osaka
072-366-0221
huemura@med.kindai.ac.jp
1st name | Masahiro |
Middle name | |
Last name | Nozawa |
Kindai University Faculty of Medicine
Department of Urology
5898511
377-2, Ohno-higashi, Osaka-sayama, Osaka
072-366-0221
nozawa06@med.kindai.ac.jp
Kindai University Faculty of Medicine
ONO PHARMACEUTICAL CO., LTD.
Bristol-Myers Squibb
Profit organization
Kindai University Faculty of Medicine
377-2, Ohno-higashi, Osaka-sayama, Osaka
072-366-0221
nozawa06@med.kindai.ac.jp
NO
2018 | Year | 03 | Month | 28 | Day |
Unpublished
Open public recruiting
2017 | Year | 07 | Month | 26 | Day |
2018 | Year | 01 | Month | 23 | Day |
2018 | Year | 10 | Month | 17 | Day |
2023 | Year | 09 | Month | 30 | Day |
Duration of response
Objective response
Time to response
Progression-free survival
Overall survival
Adverse events
2018 | Year | 03 | Month | 28 | Day |
2019 | Year | 03 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036474
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |